Assessment of Methods Used in Evaluating Balance Rehabilitation in Parkinson's Patients

Balance rehabilitation holds an important place in the treatment of Parkinson's patients. Before and after treatment, patients are evaluated using various measurement methods. In calculations of changes post-treatment, although statistically significant changes are detected, clinical differences are often not observed. Jaeschke et al. developed the concept of minimal clinically important difference (MCID) to address this. They have worked on methods to determine the level of MCID. These measurements help clinicians understand which results can be interpreted as clinically meaningful for the patient. Responsiveness refers to how sensitive a measurement tool is to changes, whereas MCID focuses on determining whether these changes are clinically significant. Both concepts are crucial for understanding and interpreting the performance of measurement tools. Identifying which patients have a high risk of balance problems and falls, and screening those at risk, is important for making treatment decisions. Determining which change values are clinically significant (MCID) and identifying which tests are more sensitive in detecting changes (responsiveness) are essential in monitoring patients.

NCT Number	NCT06562686
Lead Sponsor	Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Conditions	Parkinson Disease
Enrollment	83 participants
Start Date	2024-08
Primary Completion	2025-04 (estimated)
Study Completion	2025-07 (estimated)
Updated on ClinicalTrials.gov	2024-08-20